Cargando…

Performance of Screening Tools in Detecting Major Depressive Disorder among Patients with Coronary Heart Disease: A Systematic Review

BACKGROUND: Major depressive disorder (MDD) is common in patients with coronary heart disease (CHD) and there is no consensus on the optimal screening tool for use in identifying MDD. This study aimed to systematically review the performance of various screening tools in the identification of MDD. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Yanping, Yang, Hui, Browning, Colette, Thomas, Shane, Liu, Meiyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2015
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4354444/ https://www.ncbi.nlm.nih.gov/pubmed/25725615 http://dx.doi.org/10.12659/MSM.892537

Ejemplares similares

Final validation of the mental health screening tool for depressive disorders: A brief online and offline screening tool for major depressive disorder
por: Park, Kiho, et al.
Publicado: (2022)

Web-based tools can be used reliably to detect patients with major depressive disorder and subsyndromal depressive symptoms
por: Lin, Chao-Cheng, et al.
Publicado: (2007)

The development of the visual screening tool for anxiety disorders and depression: Addressing barriers to screening for depression and anxiety disorders in hypertension and/or diabetes
por: Ogle, Zimbini, et al.
Publicado: (2018)

Amygdala substructure volumes in Major Depressive Disorder
por: Roddy, Darren, et al.
Publicado: (2021)

Heart Rate Variability for the Prediction of Treatment Response in Major Depressive Disorder
por: Choi, Kwan Woo, et al.
Publicado: (2020)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
por: Choi, Hyebin, et al.
Publicado: (2021)

Causal association between major depressive disorder and coronary heart disease: a two-sample bidirectional mendelian randomization study
por: Xu, Qianjie, et al.
Publicado: (2023)

Heart rate variability (HRV) in adolescent females with anxiety disorders and major depressive disorder
por: Henje Blom, E, et al.
Publicado: (2010)

The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder
por: Dijkstra, Francis M, et al.
Publicado: (2022)

Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women
por: van Heyningen, Thandi, et al.
Publicado: (2018)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Automatic detection of major depressive disorder using electrodermal activity
por: Kim, Ah Young, et al.
Publicado: (2018)

Adaptive Multimodal Neuroimage Integration for Major Depression Disorder Detection
por: Wang, Qianqian, et al.
Publicado: (2022)

Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder
por: McNamara, Robert K.
Publicado: (2009)

Cognitive performance and brain structural connectome alterations in major depressive disorder
por: Gruber, Marius, et al.
Publicado: (2023)

Screening for a false unipolarity in patients treated for a major depressive disorder
por: Regaieg, N., et al.
Publicado: (2021)

Depression and Coronary Heart Disease
por: Davidson, Karina W.
Publicado: (2012)

The validation of the visual screening tool for anxiety disorders and depression in hypertension and/or diabetes
por: Ogle, Zimbini, et al.
Publicado: (2018)

Population health surveys and screening tools for depressive disorders: aims and uses
por: Arias de la Torre, Jorge, et al.
Publicado: (2023)

Temperament and major depressive disorder
por: Karam, Elie G, et al.
Publicado: (2010)

Neurobiology of Major Depressive Disorder
por: Villanueva, Rosa
Publicado: (2013)

Lipidomics in Major Depressive Disorder
por: Walther, Andreas, et al.
Publicado: (2018)

SUMOylation and Major Depressive Disorder
por: Jeoung, Seok-Won, et al.
Publicado: (2022)

The self-reported Montgomery-Åsberg depression rating scale is a useful evaluative tool in major depressive disorder
por: Fantino, Bruno, et al.
Publicado: (2009)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

Microstructural deficits of the thalamus in major depressive disorder
por: Zhang, Yuxuan, et al.
Publicado: (2022)

Validation of the Thai version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E): Screening for major depressive disorder in patients with epilepsy
por: Kuladee, S., et al.
Publicado: (2023)

Prevalence and factors associated with metabolic syndrome in first hospitalization for major depression disorder patients
por: Tang, Zhongyu, et al.
Publicado: (2023)

Implementing Chronic Disease Self-Management Approaches in Australia and the United Kingdom
por: Browning, Colette Joy, et al.
Publicado: (2015)

Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder
por: Ho, Roger C. M., et al.
Publicado: (2018)

Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease
por: Dennis, Jessica, et al.
Publicado: (2019)

Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
por: Hammer-Helmich, Lene, et al.
Publicado: (2018)

Exhausted Heart Rate Responses to Repeated Psychological Stress in Women With Major Depressive Disorder
por: Schiweck, Carmen, et al.
Publicado: (2022)

Longitudinal Association of Universal Screening and Treatment for Major Depressive Disorder with Survival in Cancer Patients
por: Yen, Yung-Chieh, et al.
Publicado: (2022)

Validity of the Liverpool Adverse Events Profile as a Screening Tool for Detecting Comorbid Depression or Anxiety Disorder in People with Epilepsy
por: Kwon, Oh-Young, et al.
Publicado: (2018)

Accuracy of three depression screening scales to diagnose major depressive episodes in older adults without neurocognitive disorders
por: Costa, Mônica V., et al.
Publicado: (2016)

Erratum: The validation of the visual screening tool for anxiety disorders and depression in hypertension and/or diabetes
por: Ogle, Zimbini, et al.
Publicado: (2019)

Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group
por: Han, Laura K. M., et al.
Publicado: (2020)

Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder
por: Air, Tracy, et al.
Publicado: (2015)

Game Theory Paradigm: A New Tool for Investigating Social Dysfunction in Major Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mfm7c83kqegeuskifrg20q9bac